Insight

Vittorio Studiale: Late-line mCRC – an evidence-based algorithm for the clinical practice in 2024

Vittorio Studiale/X

Nov 19, 2024, 20:59

Vittorio Studiale: Late-line mCRC – an evidence-based algorithm for the clinical practice in 2024

Vittorio Studiale, Medical Oncology Resident at Pisa University Hospital, shared a post on X about a recent paper by him and colleagues published in Nature Reviews Clinical Oncology:

“Late-line mCRC: an evidence-based algorithm for the clinical practice in 2024.

Proud and thrilled to share our review on the topic now online in Nature Reviews Clinical Oncology.”

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm.”

Authors: Paolo Ciracì, Vittorio Studiale, Ada Taravella, Carlotta Antoniotti, Chiara Cremolini.

Vittorio Studiale: Late-line mCRC - an evidence-based algorithm for the clinical practice in 2024

For more posts like this, visit oncodaily.com.

Ada Taravella cancer Carlotta Antoniotti Chiara Cremolini mCRC Metastatic colorectal cancer Nature Reviews Clinical Oncology OncoDaily Oncology Paolo Ciracì Vittorio Studiale

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage